TRED Program
Paul Calabresi Clinical Oncology K12 Program
Paul Calabresi Clinical Oncology K12 Program Scholars
- Orwa Aboud, M.D., Ph.D.
Exploiting tumor metabolomic remodeling to predict treatment response and tumor recurrence in glioblastoma patients - Ebaa F. Al-Obeidi, M.D.
Signed in Blood: Plasma circulating tumor DNA kinetics as an early biomarker of treatment response and disease recurrence in pancreatic cancer - Erin Brown, M.D.
Engineered Placental Mesenchymal Stem Cells As A Cellular Therapy Vehicle For Neuroblastoma Treatment - Naseem Esteghamat, M.D., M.S.
Non-Investigational Drug Study to Collect Bone Marrow from Subjects with Metastatic or Unresectable Solid Tumors to Evaluate the Ability to Expand Marrow Infiltrate T-Cells - Alex Fauer, Ph.D., R.N.
Career Development Award in Community-Based, tailored Survivorship Care - Felipe Godinez, Ph.D.
The Role of Interventional MRI for Targeted Drug Delivery in Brain Cancer - Yin Allison Liu, M.D., Ph.D.
Ophthalmic and genetic biomarkers for treatment-associated cognitive dysfunction in patients with low-grade gliomas - Shiruyeh Schokrpur, M.D., Ph.D.
Using novel preclinical models of lung squamous cell carcinoma to guide breakthroughs in combination immunotherapies - Surbhi Singhal, M.D.
A novel plasma proteomic biomarker to predict treatment efficacy of immune checkpoint inhibitors among older adults and patients with refractory non-small cell lung cancer - Christine M. Toedebusch, D.V.M., Ph.D.
Uncovering the therapeutic potential of the TGFbeta-GAM-OLFML3 signaling axis in glioblastoma multiforme - Siao-Yi Wang, M.D., Ph.D.
Improving a cell-based immunotherapeutic model from patient-derived head and neck squamous cell carcinoma through modulation of the tumor microenvironment
- Gustavo Barisone, Ph.D.
Phase I/II Trial of FWGP in Patients With NHL Receiving Rituximab Therapy - Andrew Birkeland, M.D.
Translating Image-Guided Surgery With Nanotheranostics From Animal Models to Patients - Jenna Burton, D.V.M., M.S., D.A.C.V.I.M.
Contributions of B-Cell Lymphoma Microenvironment in the Development of Drug Resistance - Robert Canter, M.D,. M.A.S., F.A.C.S.
Exploring Novel Treatment Approaches in Soft Tissue Sarcoma - Janai Carr-Ascher, M.D., Ph.D.
Development of a Phenotypically Diverse Sarcoma Pre-Clinical Disease Model to Identify Novel Therapeutic Approaches - Luis Carvajal-Carmona, B.Sc., Ph.D.
Colorectal Cancer Gene Discovery in Hispanics Through Whole Genome Sequencing - May Cho, M.D.
Development of Oxaliplatin-DNA Adduct Formation as a Biomarker in Gastrointestinal Malignancies - Megan Daly, M.D.
Extending the Benefit of Immunotherapy for Metastatic Non-Small Cell Lung Cancer With Ablative Radiation - Elizabeth David, M.D., F.A.C.S.
Understanding Decision-Making for Surgery in Advanced Stage Non-Small Cell Lung Cancer Patients - Sepideh Gholami, M.D., F.A.C.S.
Investigation of Immune-Mediated Treatments Strategies for Colorectal Liver Metastases - Brian Jonas, M.D., Ph.D.
A Daunorubicin and Cytarabine Microdosing Feasibility Study in Adult Acute Myeloid Leukemia - Edward Kim, M.D., Ph.D.
Aurora Kinase Inhibition in Pancreatic Cancer - Amanda Kirane, M.D.
Assessment of Immune Phenotype and Patterns of Response to Neoadjuvant Oncolytic Virus in High Risk, Resectable Melanoma - Maija Kiuru, M.D., Ph.D.
Molecular Subtyping of Nevi and Melanoma To Improve Diagnostic Accuracy and Identify Drivers of Melanomagenesis - Tzu-yin (Cindy) Lin, D.V.M., Ph.D.
Multi-Functional Bladder-Targeting Nanoporphyrin Medicated Phototherapy to Potentiate Immunotherapy - Chengfei Liu, M.D., Ph.D.
Targeting Steroidogenesis Pathway Overcomes Next Generation Anti-Androgen Resistance in Advanced Prostate Cancer - Lorenzo Nardo, M.D., Ph.D.
Optimized PET/CT: Clinical Applications in Lung Cancer - Mamta Parikh, M.D., M.S.
Pilot Study Evaluating Safety of Selinexor and Its Effect on XPO1 Expression in Bladder and Renal Cancers - Jonathan Riess, M.D.
Resistance To Epidermal Growth Factor Receptor Tyrosine Linase Inhibitors (EGFR-TKIs) by Linking Patient Derived Lung Cancer Xenotransplants To Clinical Trials - Aaron Seth Rosenberg, M.D., M.S.
Evaluating High Dose Melphalan Pharmacokinetics, Predictors of Variability, and Its Effect on Toxicity and Efficacy - Thomas Semrad, M.D., M.A.S.
Eliminating Resistance To Anti-Vascular Endothelial Growth Factor (VEGF) Therapy Through Translational Clinical Trials and Alternative Angiogenic Pathway - Guobao Wang, Ph.D.
School of Medicine Dean's Scholar in Clinical Oncology
One-Stop Shop Multiparametric PET Imaging of Cancer Treatment Response and Organ Chemotoxicity for Targeted Therapy